Large germline deletions of the CYLD gene in patients with Brooke-Spiegler syndrome and multiple familial trichoepithelioma
Language English Country United States Media print
Document type Journal Article
PubMed
25347032
DOI
10.1097/dad.0000000000000068
PII: 00000372-201411000-00002
Knihovny.cz E-resources
- MeSH
- Biopsy MeSH
- Neoplastic Syndromes, Hereditary genetics pathology MeSH
- Deubiquitinating Enzyme CYLD MeSH
- Adult MeSH
- Phenotype MeSH
- Genetic Predisposition to Disease MeSH
- Gene Rearrangement MeSH
- Middle Aged MeSH
- Humans MeSH
- Adolescent MeSH
- Young Adult MeSH
- Molecular Sequence Data MeSH
- INDEL Mutation * MeSH
- DNA Mutational Analysis MeSH
- Biomarkers, Tumor genetics MeSH
- Tumor Suppressor Proteins genetics MeSH
- Skin Neoplasms genetics pathology MeSH
- Pedigree MeSH
- Base Sequence MeSH
- Sequence Deletion * MeSH
- Comparative Genomic Hybridization MeSH
- Germ-Line Mutation * MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Adolescent MeSH
- Young Adult MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- CYLD protein, human MeSH Browser
- Deubiquitinating Enzyme CYLD MeSH
- Biomarkers, Tumor MeSH
- Tumor Suppressor Proteins MeSH
Brooke-Spiegler syndrome (BSS) and its phenotypic variants, multiple familial trichoepithelioma (MFT) and familial cylindromatosis, are rare autosomal dominant hereditary diseases. They are characterized by the presence of multiple adnexal tumors, especially cylindromas, spiradenomas, spiradenocylindromas, and trichoepitheliomas. Implicated in the pathogenesis of the disease is the gene CYLD, which is localized on the long arm of chromosome 16. This gene encodes an evolutionarily conserved protein belonging to the deubiquitinating enzymes family, which plays a key role in many signaling pathways, especially in NF-κB, JNK, and Wnt. Less than 90 germline mutations of CYLD have been identified in patients with BSS/MFT. These mutations are mostly small alterations in the coding sequence and at exon-intron junction sites. One patient with an intronic mutation and another with a large CYLD deletion have also been recorded. In this study, the authors have analyzed a cohort of 14 patients with BSS/MFT from 13 families for large genome rearrangements by array comparative genome hybridization followed by confirmatory sequencing. We identified 2 large deletions, namely c.-34111_*297858del378779 and c.914-6398_1769del13642ins20 in patients with MFT and BSS, respectively. All other analyzable patients did not reveal any copy number alteration. It is concluded that the large rearrangements are relatively rare in patients without a germline CYLD mutation demonstrable by conventional sequencing. The pathogenetic mechanisms in patients with BSS/MFT lacking germline sequence alterations or large rearrangements in the CYLD gene remain to be clarified.
References provided by Crossref.org
Brooke-Spiegler Syndrome and Phenotypic Variants: An Update
Overexpression of MYB drives proliferation of CYLD-defective cylindroma cells